BCL2 and viral infectious disease: In addition, no obvious effect on protein level accumulation of BCL2 was detected after treating nonviruliferous SBPH with dsSOCS5 compared with the control (Fig 3D, lanes 1 vs. 2), suggesting that SOCS5 imposes a negative effect on BCL2 accumulation during viral infection.